Cargando…

Statins and endocrine resistance in breast cancer

Most breast cancers are hormone-receptor positive (HR(+)). However, more women eventually die from HR(+) breast cancer than from either HER2(+) or triple negative breast cancer. Endocrine therapies continue to be the mainstay of treatment. In 40% of these cases, recurrences in early-stage disease an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyder, Tara, Marti, Juan Luis Gomez, Nasrazadani, Azadeh, Brufsky, Adam M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019265/ https://www.ncbi.nlm.nih.gov/pubmed/35582035 http://dx.doi.org/10.20517/cdr.2020.112

Ejemplares similares

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection
por: Brufsky, Adam, et al.
Publicado: (2020)

Ovarian function suppression as a potential mechanism of chemotherapy
por: Gomez Marti, Juan Luis, et al.
Publicado: (2021)

Artificial intelligence-directed prognostication of breast cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2019)

Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer
por: Gomez Marti, Juan Luis, et al.
Publicado: (2023)

Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
por: Hyder, Tara, et al.
Publicado: (2021)

Breast cancer mortality as a function of age
por: Nasrazadani, Azadeh, et al.
Publicado: (2022)

Statin drugs to reduce breast cancer recurrence and mortality
por: Beckwitt, Colin H., et al.
Publicado: (2018)

Current Approaches and Emerging Directions in HER2-resistant Breast Cancer
por: Brufsky, Adam M
Publicado: (2014)

Machine Learning to Discern Interactive Clusters of Risk Factors for Late Recurrence of Metastatic Breast Cancer
por: Gomez Marti, Juan Luis, et al.
Publicado: (2022)

Voltage-Gated Calcium Channel Antibody-Induced Oropharyngeal Dysphagia Presenting as a Paraneoplastic Neurological Complication in Breast Cancer
por: Khanam, Razwana, et al.
Publicado: (2021)

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer
por: Foldi, Julia, et al.
Publicado: (2023)

Exploring new pathways in endocrine-resistant breast cancer
por: de Pinho, Inês Soares, et al.
Publicado: (2022)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings
por: Brufsky, Adam
Publicado: (2017)

The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
por: Martí, Covadonga, et al.
Publicado: (2021)

New insights into acquired endocrine resistance of breast cancer
por: Fan, Ping, et al.
Publicado: (2019)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Puhalla, Shannon, et al.
Publicado: (2008)

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
por: Brufsky, Adam M.
Publicado: (2015)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
por: Jeffreys, Sarah A., et al.
Publicado: (2020)

Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer
por: Brufsky, Adam M.
Publicado: (2014)

The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer
por: La Camera, Giusi, et al.
Publicado: (2021)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

A Role for Notch Signalling in Breast Cancer and Endocrine Resistance
por: Acar, Ahmet, et al.
Publicado: (2016)

Endocrine Relationships in Breast Cancer
por: Barnes, D. M.
Publicado: (1982)

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
por: D’Souza, Anishka, et al.
Publicado: (2018)

Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
por: Szostakowska, Małgorzata, et al.
Publicado: (2018)

Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
por: Takeiwa, Toshihiko, et al.
Publicado: (2020)

In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
por: Cheng, Gary J., et al.
Publicado: (2022)

Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment
por: Li, Yuan, et al.
Publicado: (2021)

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
por: Steinman, Richard A, et al.
Publicado: (2012)

Endocrine disruptors from the environment affecting breast cancer
por: Calaf, Gloria M., et al.
Publicado: (2020)

ENDOCRINE ASPECTS OF BREAST CANCER
Publicado: (1958)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

Endocrine resistant breast cancer: brain metastasis
por: Willman, Matthew, et al.
Publicado: (2022)

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
por: Hayes, Erin L, et al.
Publicado: (2015)

Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches
por: Shete, Nivida, et al.
Publicado: (2023)

Statins: a role in breast cancer therapy?
por: Borgquist, S., et al.
Publicado: (2018)

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer
por: Nicholson, RI, et al.
Publicado: (2000)

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
por: Hartmaier, R J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_88s8adob0nvjeoj7qjdfonvhb2